Syndax Pharmaceuticals Statistics
Total Valuation
SNDX has a market cap or net worth of $1.96 billion. The enterprise value is $1.52 billion.
Market Cap | 1.96B |
Enterprise Value | 1.52B |
Important Dates
The next estimated earnings date is Thursday, August 1, 2024, after market close.
Earnings Date | Aug 1, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
SNDX has 84.99 million shares outstanding. The number of shares has increased by 22.72% in one year.
Shares Outstanding | 84.99M |
Shares Change (YoY) | +22.72% |
Shares Change (QoQ) | +17.46% |
Owned by Insiders (%) | 0.82% |
Owned by Institutions (%) | 108.94% |
Float | 84.65M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 3.99 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.93, with a Debt / Equity ratio of 0.00.
Current Ratio | 8.93 |
Quick Ratio | 8.85 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1,078.08 |
Financial Efficiency
Return on equity (ROE) is -53.30% and return on invested capital (ROIC) is -53.41%.
Return on Equity (ROE) | -53.30% |
Return on Assets (ROA) | -48.50% |
Return on Capital (ROIC) | -53.41% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.31M |
Employee Count | 184 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.12% in the last 52 weeks. The beta is 0.94, so SNDX's price volatility has been similar to the market average.
Beta (5Y) | 0.94 |
52-Week Price Change | +6.12% |
50-Day Moving Average | 20.86 |
200-Day Moving Average | 19.75 |
Relative Strength Index (RSI) | 58.75 |
Average Volume (20 Days) | 1,172,199 |
Short Selling Information
The latest short interest is 8.34 million, so 9.82% of the outstanding shares have been sold short.
Short Interest | 8.34M |
Short Previous Month | 9.92M |
Short % of Shares Out | 9.82% |
Short % of Float | 9.86% |
Short Ratio (days to cover) | 6.58 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -263.45M |
Pretax Income | -240.63M |
Net Income | -240.63M |
EBITDA | -239.53M |
EBIT | -240.41M |
Earnings Per Share (EPS) | -$3.23 |
Balance Sheet
The company has $443.38 million in cash and $1.39 million in debt, giving a net cash position of $441.99 million or $5.20 per share.
Cash & Cash Equivalents | 443.38M |
Total Debt | 1.39M |
Net Cash | 441.99M |
Net Cash Per Share | $5.20 |
Equity (Book Value) | 491.89M |
Book Value Per Share | 5.79 |
Working Capital | 403.09M |
Cash Flow
Operating Cash Flow | -204.92M |
Capital Expenditures | n/a |
Free Cash Flow | -204.92M |
FCF Per Share | -$2.41 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
SNDX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -22.72% |
Shareholder Yield | -22.72% |
Earnings Yield | -12.27% |
FCF Yield | -10.45% |
Analyst Forecast
The average price target for SNDX is $35.25, which is 52.73% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $35.25 |
Price Target Difference | 52.73% |
Analyst Consensus | Strong Buy |
Analyst Count | 12 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -38.52% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |